Literature DB >> 18073513

Endocannabinoids in TNF-alpha and ethanol actions.

Valeria Rettori1, Javier Fernandez-Solari, Juan P Prestifilippo, Claudia Mohn, Andrea De Laurentiis, Stefan R Bornstein, Monika Ehrhart-Bornstein, Juan C Elverdin, Samuel M McCann.   

Abstract

During marijuana and alcohol consumption as well as during inflammation the reproductive axis is inhibited, mainly through the inhibition of luteinizing hormone-releasing hormone release. In male rats, this inhibitory effect is mediated, at least in part, by the activation of hypothalamic cannabinoid type 1 receptors (CB1). During inflammation, this activation of the endocannabinoid system seems to be mediated by an increase in TNF-alpha production followed by anandamide augmentations, similarly the effect of intragastric administration of ethanol (3 g/kg) seems to be due to an increase in anandamide. On the other hand, a number of different actions mediated by the endocannabinoid system in various organs and tissues have been described. Both cannabinoid receptors, CB1 and CB2, are localized in the submandibular gland where they mediate the inhibitory effect of intrasubmandibular injections of the endocannabinoid anandamide (6 x 10(-5)M) on salivary secretion. Lipopolysaccharide (5 mg/kg/3 h) injected intraperitoneally and ethanol (3 g/kg/1 h) injected intragastrically inhibited the salivary secretion induced by the sialogogue metacholine; this inhibitory effect was blocked by CB1 and/or CB2 receptor antagonists. Similar to the hypothalamus, these effects seem to be mediated by increased anandamide. In summary, similar mechanisms mediate the inhibitory actions of endocannabinoids and cannabinoids in both hypothalamus and submandibular gland during drug consumption and inflammation. Copyright 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18073513     DOI: 10.1159/000110645

Source DB:  PubMed          Journal:  Neuroimmunomodulation        ISSN: 1021-7401            Impact factor:   2.492


  3 in total

1.  Type 1 cannabinoid receptor-containing axons innervate hypophysiotropic thyrotropin-releasing hormone-synthesizing neurons.

Authors:  Levente Deli; Gábor Wittmann; Imre Kalló; Ronald M Lechan; Masahiko Watanabe; Zsolt Liposits; Csaba Fekete
Journal:  Endocrinology       Date:  2008-09-25       Impact factor: 4.736

2.  Cannabinoid CB1 receptors regulate salivation.

Authors:  Kelsey Andreis; Jenna Billingsley; Kian Naimi Shirazi; Jim Wager-Miller; Clare Johnson; Heather Bradshaw; Alex Straiker
Journal:  Sci Rep       Date:  2022-08-19       Impact factor: 4.996

Review 3.  Endocannabinoid System in the Neuroendocrine Response to Lipopolysaccharide-induced Immune Challenge.

Authors:  Andrea De Laurentiis; Fernando Correa; Javier Fernandez Solari
Journal:  J Endocr Soc       Date:  2022-08-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.